Suppression of the neoplastic phenotype by transfection of phospholipase C beta 3 to neuroendocrine tumor cells

FEBS Lett. 1999 May 7;450(3):210-6. doi: 10.1016/s0014-5793(99)00457-3.

Abstract

The expression of phospholipase C beta 3 (PLCB3) is low or absent in several neuroendocrine neoplasias. To investigate the role of PLCB3 in the neuroendocrine tumorigenesis, we transfected a PLCB3 construct to three neuroendocrine tumor cell lines with a low PLCB3 expression. The growth rate and tumorigenicity were assessed in vitro by [3H]thymidine incorporation and cell counting, in vivo, by xenografting to nude mice. In vitro, PLCB3 expressing clones showed a significant growth inhibition. The tumor weight was reduced for one of the two xenografted PLCB3-transfected cell lines and in both, a reduced number of proliferating (Ki-67 positive) cells was observed. This study implies an essential role for PLCB3 in the neuroendocrine tumorigenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Division
  • Female
  • Humans
  • Isoenzymes / biosynthesis*
  • Isoenzymes / genetics
  • Ki-67 Antigen / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neuroendocrine Tumors / enzymology*
  • Neuroendocrine Tumors / etiology
  • Phenotype
  • Phospholipase C beta
  • Rats
  • Transfection
  • Tumor Cells, Cultured
  • Type C Phospholipases / biosynthesis*
  • Type C Phospholipases / genetics

Substances

  • Isoenzymes
  • Ki-67 Antigen
  • Type C Phospholipases
  • PLCB3 protein, human
  • Phospholipase C beta
  • Plcb3 protein, mouse
  • Plcb3 protein, rat